Other benign neoplasms of connective and other soft tissue
Chapter 2:Neoplasms
ICD-10 D21 is a billable code used to indicate a diagnosis of other benign neoplasms of connective and other soft tissue.
D21 encompasses a variety of benign neoplasms that arise from connective tissues and other soft tissues, excluding those specifically classified under other codes. These neoplasms can occur in various locations throughout the body, including the skin, subcutaneous tissue, muscle, and fibrous tissues. Common examples include lipomas, fibromas, and neurofibromas. Clinically, these tumors are typically asymptomatic and may be discovered incidentally during imaging or physical examinations. While benign, they can cause discomfort or functional impairment depending on their size and location. Management often involves observation, surgical excision, or other interventions if symptomatic. Follow-up care is essential to monitor for any changes in size or symptoms, ensuring that any potential complications are addressed promptly. The benign nature of these neoplasms generally leads to a favorable prognosis, but accurate coding is crucial for proper treatment documentation and reimbursement.
Detailed pathology reports and imaging studies to confirm benign nature.
Management of soft tissue tumors, including surgical excision and follow-up care.
Ensure clear documentation of tumor type and location to avoid misclassification.
Photographic evidence and biopsy results for skin lesions.
Evaluation and treatment of cutaneous benign neoplasms.
Document any changes in size or symptoms during follow-up visits.
Used when a benign neoplasm is surgically excised.
Document the size, location, and pathology results.
Ensure that the excision is clearly linked to the diagnosis of a benign neoplasm.
D21 includes various benign neoplasms such as lipomas, fibromas, and neurofibromas, which arise from connective and soft tissues.
Documentation should include the type of neoplasm, its location, size, and any symptoms or treatment provided.
